• # LGM Pharma is a Perindopril CAS# 82834-16-0 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Perindopril
  • CAS #: 82834-16-0
  • IUPAC: 11H-Indole-2-carboxylic acid, octahydro-1-(2-((1-ethoxycarbonyl)butyl)amino)-1-oxopropyl)-, (2S-(1(R*(R*)), 2-alpha, 3a-beta, 7a-beta))-
  • ATC: C09AA04 C09BA04(with[[diuretic]]s)C09BB04(with[[amlodipine]])
  • PubChem: 107807
  • DrugBank: APRD01178
  • Formula: C19H32N2O5
  • Molecular Mass: 368.468
  • Synonyms: (2S,3aS,7aS)-1-((S)-N-((S)-1-Carboxybutyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, 1H-Indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-, (2S-(1(R*(R*)),2alpha,3abeta,7abeta))-, BRN 4300272, Coversyl, McN-A 2833, McN-A-2833, Perindopril, Perindoprilum, Perindoprilum [Latin], S 9490, S-9490, UNII-Y5GMK36KGY
  • SMILES: N1([C@@H]2[C@@H](CCCC2)C[C@H]1C(O)=O)C([C@H](N[C@H](C(OCC)=O)CCC)C)=O
  • InChl: InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13-,14-,15-,16-/m0/s1
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants


  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements
This website uses cookies. By using our site, you agree to our terms of service